<DOC>
	<DOCNO>NCT02097043</DOCNO>
	<brief_summary>This study phase I clinical trial evaluate pharmacokinetics safety/tolerability DA-7218 healthy male volunteer .</brief_summary>
	<brief_title>Phase I Clinical Study Investigate Pharmacokinetics Safety/Tolerability DA-7218 Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Torezolid phosphate</mesh_term>
	<criteria>Healthy male Korean 1945 year Body weight:5590kg , BMI:18.027.0 Present condition history clinically significant disease Clinical evidence history GI disease history GI surgery History hypersensitivity , include drug allergy AST ( SGOT ) ALT ( SGPT ) &gt; 1.5 time upper normal limit Systolic blood pressure : &lt; 100 mmHg &gt; 160 mmHg Diastolic blood pressure : &lt; 60 mmHg &gt; 100 mmHg Drug abuse within 2 month , positive reaction abusive drug cotinine Taken ETC herbal supplement within 2 week OTC vitamin supplement within 1 week Participation administration IP another clinical trial within 2 month Donation whole blood within 2 month , blood component within 1 month , receipt blood transfusion within 1 month Consumption 21 unit alcohol/week inability abstain drink study period Smoking within 3 month Taking caffeine grapefruitcontaining product within 3 day Plan pregnant , use appropriate method contraception</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>